CommercialCoverageMedium impact
BreastCare/BreastAlert Differential Temperature Sensor (CPB 0337, reviewed 2026-05-21)
Aetna·Oncology, Radiology, OB-GYN +1 more·Medical Policy
Effective date
Jun 29, 1999
We identified it
Aug 19, 2026
Summary
Aetna is clarifying that the BreastCare/BreastAlert Differential Temperature Sensor device remains non-covered as experimental, investigational, or unproven. This policy was last reviewed on May 21, 2026, and effective June 29, 1999. Billing teams must ensure claims for this device are denied and providers are informed that this technology is not a reimbursable screening or diagnostic tool.
Action Required
Immediately: Billing team must ensure that any claims submitted for BreastCare/BreastAlert Differential Temperature Sensor device (CPB 0337) are automatically denied as non-covered/experimental. Update billing system to flag and reject any submissions associated with this device. Create denial language in claim response templates stating the device is experimental and lacks sufficient clinical evidence. Educate in-house providers and contracted providers that this device is not a billable service under Aetna plans. Route any provider appeals related to this device to medical policy review. Do not process reimbursement for CPT codes 77066 or 77067 when billed specifically for BreastAlert differential temperature sensing technology. Verify that EHR/practice management system templates do not suggest coding for this device during breast cancer screening encounters.